Yanmei Lin

Development of an affinity-enhanced clinical candidate TCR targeting NY-ESO-1 with optimal potency and high specificity

Siyun Li, Haiping Gong, Kai Zhan, 2022, bioRxiv.

Identification of peptide-specific TCR genes by in vitro peptide stimulation and CDR3 length polymorphism analysis.

Wen-feng Zhang, Han Shen, Changli Tao, 2015, Cancer letters.

Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma

Jing Yang, J. Lau, Jiewen Chen, 2023, Cell Reports Medicine.